IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MAGRINI, STEFANO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.890
AS - Asia 10.191
EU - Europa 8.386
SA - Sud America 2.453
AF - Africa 208
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 18
Totale 39.171
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.607
CN - Cina 3.444
SG - Singapore 3.366
UA - Ucraina 2.336
BR - Brasile 2.099
HK - Hong Kong 1.538
DE - Germania 1.368
IT - Italia 1.118
VN - Vietnam 633
FI - Finlandia 627
PL - Polonia 546
IE - Irlanda 545
RU - Federazione Russa 464
GB - Regno Unito 434
TR - Turchia 431
FR - Francia 418
IN - India 208
AR - Argentina 139
CA - Canada 139
SE - Svezia 124
BD - Bangladesh 118
MX - Messico 82
NL - Olanda 82
IQ - Iraq 77
EC - Ecuador 75
ID - Indonesia 74
ZA - Sudafrica 74
EE - Estonia 65
CZ - Repubblica Ceca 53
JP - Giappone 50
UZ - Uzbekistan 38
ES - Italia 35
MA - Marocco 35
CO - Colombia 34
VE - Venezuela 32
BE - Belgio 31
PK - Pakistan 31
AT - Austria 30
PY - Paraguay 29
SA - Arabia Saudita 25
EU - Europa 23
KE - Kenya 22
GR - Grecia 19
JO - Giordania 18
IL - Israele 16
LT - Lituania 16
TN - Tunisia 16
AU - Australia 15
CL - Cile 15
EG - Egitto 15
AZ - Azerbaigian 14
PE - Perù 14
NP - Nepal 13
AE - Emirati Arabi Uniti 12
DO - Repubblica Dominicana 12
MY - Malesia 10
DZ - Algeria 9
IR - Iran 9
JM - Giamaica 9
KG - Kirghizistan 9
KZ - Kazakistan 9
OM - Oman 9
BG - Bulgaria 8
BY - Bielorussia 8
CH - Svizzera 8
PA - Panama 8
UY - Uruguay 8
AL - Albania 7
BO - Bolivia 7
LA - Repubblica Popolare Democratica del Laos 7
SN - Senegal 7
TT - Trinidad e Tobago 7
DK - Danimarca 6
HN - Honduras 6
KW - Kuwait 6
MU - Mauritius 6
PT - Portogallo 6
BB - Barbados 5
CR - Costa Rica 5
HU - Ungheria 5
LV - Lettonia 5
ET - Etiopia 4
KR - Corea 4
LB - Libano 4
MK - Macedonia 4
NG - Nigeria 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UG - Uganda 4
AO - Angola 3
CI - Costa d'Avorio 3
KH - Cambogia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
AM - Armenia 2
BW - Botswana 2
GE - Georgia 2
GT - Guatemala 2
IS - Islanda 2
Totale 39.143
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.781
Fairfield 1.744
Woodbridge 1.608
Singapore 1.597
Hong Kong 1.533
Ashburn 1.474
Houston 1.160
Ann Arbor 899
Princeton 806
Chandler 803
Cambridge 775
Beijing 713
Wilmington 702
Seattle 694
Nanjing 579
Dublin 541
Warsaw 538
New York 420
Los Angeles 377
Istanbul 361
The Dalles 315
Dearborn 268
Helsinki 259
Nanchang 219
Ho Chi Minh City 216
Buffalo 205
Dallas 202
Des Moines 201
Moscow 197
São Paulo 187
Munich 171
Changsha 150
Milan 148
Brescia 146
Shenyang 139
Hebei 125
San Diego 121
Tianjin 120
Jinan 117
Shanghai 117
Hanoi 113
San Francisco 96
Jiaxing 89
Redondo Beach 76
Rio de Janeiro 74
Kunming 65
Tallinn 65
Chicago 64
Verona 62
London 60
Hangzhou 58
Dong Ket 56
Boardman 50
Rome 49
Turku 48
Santa Clara 47
Washington 47
Tokyo 46
Brasília 45
Zhengzhou 45
Belo Horizonte 44
Montreal 44
Guangzhou 42
Brooklyn 40
Lancaster 39
Nuremberg 39
Denver 38
Brno 37
Toronto 37
Johannesburg 36
Quito 35
Tashkent 35
Jakarta 34
Ningbo 34
Lanzhou 32
Orem 31
Taizhou 31
Augusta 30
Brussels 30
Dhaka 30
Phoenix 30
Atlanta 29
Curitiba 29
Norwalk 29
Haiphong 28
Poplar 28
Chennai 27
Pune 26
Salvador 26
Boston 25
Changchun 25
Da Nang 25
Porto Alegre 25
Stockholm 25
Haikou 24
Kocaeli 24
Frankfurt am Main 23
Guarulhos 23
Mexico City 23
Guayaquil 22
Totale 25.217
Salva come PNG Salva come JPEG
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 396
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 256
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 242
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 233
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 221
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 211
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 208
Pros-IT CNR: an Italian prostate cancer monitoring project 206
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 200
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 197
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 195
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 192
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 188
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 186
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 179
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 179
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 177
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 176
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 173
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 170
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 168
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 167
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 166
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 166
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 166
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 162
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 162
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 162
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 160
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 159
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 159
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 158
Role of external beam radiotherapy in the treatment of relapsing meningioma 157
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 157
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 155
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 154
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 151
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 150
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 150
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 149
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 149
Carboplatin (JM8), etoposide (VP16) and thoracic Irradiation for small cell lung cancer (S.C.L.C.): An evaluation of lung toxicity 148
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 148
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 147
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 146
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 146
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 145
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 144
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 144
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 144
From Molecular to Clinical Radiation Biology of Glioblastoma 143
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 142
"Radiotherapy versus combined modality in early stages", 141
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 141
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. 140
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 140
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 139
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 138
Extreme hypofractionation for early prostate cancer: Biology meets technology 138
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 136
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 135
Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma 134
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 134
GUROPA survey: genito-urinary radiation oncology prescription attitudes 134
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 134
Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series 133
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 132
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 131
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 131
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 130
Information Retrieval in Medicine: an Extensive Experimental Study 129
Cetuximab and Radiation Therapy in Head and Neck Cancer 129
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 128
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 128
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 127
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 127
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 127
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 126
Postoperative radiotherapy after radical prostatectomy for prostate carcinoma: the experience of the Brescia Radium Institute. 126
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study. 126
Which role for radiation therapy in ethmoid cancer? A retrospective analysis of 84 cases from a single Institution 125
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 125
Duration of androgen suppression in the treatment of prostate cancer 125
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 125
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 125
"CHEMOTHERAPY VERSUS RADIOTHERAPY IN EARLY-STAGE HODGKIN'S DISEASE: EVIDENCE OF A MORE DIFFICULT RESCUE FOR PATIENTS RELAPSED AFTER CHEMOTHERAPY" 124
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 124
A case report on how facing it problems: improving the reliability of a dicom router system through an affordable backup solution. 122
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 122
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 120
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 119
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 119
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 119
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 119
Radiotherapy in Small Cell Lung Cancer 118
Association between testicular cancer and spina bifida occulta 118
Radioterapia ("extended field") versus chemioterapia (MOPP) nel trattamento del m.di Hodgkin (stadio patologico I-IIA): risultati a 10 anni di uno studio prospettico randomizzato italiano 118
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 118
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 118
Second malignancies in Hodgkin's disease 117
Totale 15.243
Salva come PNG Salva come JPEG
Categoria #
all - tutte 204.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 204.178
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.323 0 0 0 0 0 635 130 584 781 470 523 200
2021/20222.644 143 488 47 104 44 137 113 211 155 305 229 668
2022/20232.483 449 133 72 160 173 638 8 236 305 143 83 83
2023/20242.909 131 48 253 129 119 529 91 116 826 67 81 519
2024/20256.457 44 80 35 801 819 557 714 184 557 511 1.296 859
2025/20268.064 1.172 1.913 1.118 2.165 1.102 594 0 0 0 0 0 0
Totale 39.682